APC anti-mouse CD86 Antibody

Pricing & Availability
Clone
GL-1 (See other available formats)
Regulatory Status
RUO
Other Names
B7-2, B70, Ly-58
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
GL-1_APC_090707
LPS-stimulated (3 days) C57BL/6 mouse splenocytes stained with GL-1 APC
  • GL-1_APC_090707
    LPS-stimulated (3 days) C57BL/6 mouse splenocytes stained with GL-1 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
105011 25 µg 154€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
105012 100 µg 454€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD86 is an 80 kD immunoglobulin superfamily member also known as B7-2, B70, and Ly-58. CD86 is expressed on activated B and T cells, macrophages, dendritic cells, and astrocytes. CD86, along with CD80, is a ligand of CD28 and CD152 (CTLA-4). CD86 is expressed earlier in the immune response than CD80. CD86 has also been shown to be involved in immunoglobulin class-switching and triggering of NK cell-mediated cytotoxicity. CD86 binds to CD28 to transduce co-stimulatory signals for T cell activation, proliferation, and cytokine production. CD86 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
LPS-activated CBA/Ca mouse splenic B cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The GL-1 antibody can block the mixed lymphocyte reaction in vitro and has been shown to inhibit the priming of cytotoxic T lymphocytes in vivo (along with antibodies against B7-1). Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemical staining of acetone-fixed frozen sections2,6, immunofluorescence microscopy, and in vivo and in vitro blocking of T cell responses1-6. GL-1 is not suitable for immunohistochemical staining of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 105051-105056).

Application References

(PubMed link indicates BioLegend citation)
  1. Hathcock KS, et al. 1993. Science 262:905. (Block, IP)
  2. Inaba KM, et al. 1994. J. Exp. Med. 180:1849. (Block, IHC)
  3. Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block)
  4. Krummel MF, et al. 1995. J. Exp. Med. 182:459. (Block)
  5. Liu Y, et al. 1997. J. Exp. Med. 185:251. (Block)
  6. Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  9. Turnquist HR, et al. 2007. J. Immunol. 178:7018.
  10. Klinger MB, et al. 2007. Am. J. Physiol. Requl. Integr. Comp. Physiol. 293:R677. PubMed
  11. de Verteuil DA, et al. 2014. J Immunol. 193:1121. PubMed
Product Citations
  1. Arora H, et al. 2019. Immunity. 50:418. PubMed
  2. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  3. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  4. Zenke S, et al. 2022. Nat Commun. 13:6459. PubMed
  5. Verteuil D, et al. 2014. J Immunol. 193:1121. PubMed
  6. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  7. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  8. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  9. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  10. Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
  11. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  12. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  13. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  14. Cho H, et al. 2022. Nat Commun. 13:5974. PubMed
  15. Mul Fedele ML, et al. 2020. Front Cell Infect Microbiol. 10:100. PubMed
  16. Xiao Y, et al. 2019. JCI Insight. 4:e99052. PubMed
  17. Bhattacharjee P, et al. 2018. Sci Rep. 13:e0199785. PubMed
  18. Hu M, et al. 2022. Can Respir J. 2022:5802938. PubMed
  19. Wu J, et al. 2021. Mol Med Rep. 23:. PubMed
  20. Sitnik S, et al. 2020. Mol Ther Oncolytics. 17:190. PubMed
  21. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  22. Shan M et al. 2018. Immunity. 49(4):709-724 . PubMed
  23. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  24. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  25. Wu L, et al. 2022. Front Cell Dev Biol. 9:684842. PubMed
  26. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  27. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  28. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  29. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  30. Yu X, et al. 2020. Cancer Cell. 37(6):850-866. PubMed
  31. Wang Y, et al. 2021. Cell Rep. 35:108948. PubMed
  32. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  33. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  34. Roberts LM, et al. 2021. iScience. 24:103025. PubMed
  35. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  36. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  37. Qian J, et al. 2021. Int J Mol Sci. 22:. PubMed
  38. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  39. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  40. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  41. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  42. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  43. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  44. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  45. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  46. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  47. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  48. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  49. Shepherd J 2011. Toxicol Sci. 120:68. PubMed
  50. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  51. Qiu N, et al. 2021. J Nanobiotechnology. 19:428. PubMed
  52. Gómez LA, et al. 2020. Front Microbiol. 11:1586. PubMed
  53. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  54. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  55. Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed
  56. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  57. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  58. Zhao F et al. 2018. Immunity. 48(1):147-160 . PubMed
  59. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  60. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  61. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  62. Li ZL, et al. 2021. Mol Ther Nucleic Acids. 25:502. PubMed
  63. Huang L, et al. 2021. Frontiers in Cellular and Infection Microbiology. 10:606340. PubMed
  64. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  65. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  66. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  67. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  68. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  69. Dai X, et al. 2021. Molecular Cell. 81(11):2317-2331.e6. PubMed
  70. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  71. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  72. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  73. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  74. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  75. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  76. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  77. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  78. Finkin S et al. 2019. Immunity. 51(2):324-336 . PubMed
  79. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
RRID
AB_493343 (BioLegend Cat. No. 105011)
AB_493342 (BioLegend Cat. No. 105012)

Antigen Details

Structure
Ig superfamily, 80 kD
Distribution

B cells and T cells (upregulated upon activation), macrophages, dendritic cells, and astrocytes

Function
T cell costimulation, Ig class-switching, NK cell cytotoxicity
Ligand/Receptor
CD28, CD152 (CTLA-4)
Cell Type
Astrocytes, B cells, Dendritic cells, Macrophages, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Hathcock KS, et al. 1993. Science 262:905.
3. Freeman GJ, et al. 1993. Science 262:907.
4. Carreno BM, et al. 2002. Annu. Rev. Immunol. 20:29.

Gene ID
12524 View all products for this Gene ID
UniProt
View information about CD86 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Brilliant Violet 650™ anti-mouse CD86

  • Biotin anti-mouse CD86

  • FITC anti-mouse CD86

  • PE anti-mouse CD86

  • Purified anti-mouse CD86

  • Brilliant Violet 605™ anti-mouse CD86

  • APC anti-mouse CD86

  • PE/Cyanine7 anti-mouse CD86

  • Alexa Fluor® 488 anti-mouse CD86

  • Alexa Fluor® 647 anti-mouse CD86

  • Pacific Blue™ anti-mouse CD86

  • PE/Cyanine5 anti-mouse CD86

  • Alexa Fluor® 700 anti-mouse CD86

  • PerCP/Cyanine5.5 anti-mouse CD86

  • PerCP anti-mouse CD86

  • APC/Cyanine7 anti-mouse CD86

  • Brilliant Violet 421™ anti-mouse CD86

  • Brilliant Violet 510™ anti-mouse CD86

  • PE/Dazzle™ 594 anti-mouse CD86

  • Brilliant Violet 785™ anti-mouse CD86

  • APC/Fire™ 750 anti-mouse CD86

  • TotalSeq™-A0200 anti-mouse CD86

  • TotalSeq™-B0200 anti-mouse CD86

  • Ultra-LEAF™ Purified anti-mouse CD86

  • TotalSeq™-C0200 anti-mouse CD86

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account